Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline Dosing Frequency in Bismuth Quadruple Therapy for H. pylori
NCT05431075Phase 4Completed
- Sponsor
- Shandong University
- Start
- Jul 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tetracycline in Helicobacter pylori infection (2 arms), sponsored by Shandong University. Primary endpoint: Eradication rate. Started Jul 2022; status: completed.
02
Drugs
tetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05431075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05431075.